Therapeutic potential of CDK inhibitors in MLL leukemias

被引：1
|
作者：
Frame, Sheelagh
Hogben, Morag
Munro, Clare
Blake, David G.
Green, Simon R.
Zheleva, Danielle I.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3886
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3886
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Therapeutic potential of CDK-inhibitors in hepatoblastoma
    Eichenmueller, M.
    von Schweinitz, D.
    Kappler, R.
    KLINISCHE PADIATRIE, 2012, 224 (03): : 223 - 223
  • [2] The dimerization domains of MLL are potential therapeutic targets in t(4;11)-leukemias
    Pless, B.
    Oehm, C.
    Dingermann, T.
    Marschalek, R.
    KLINISCHE PADIATRIE, 2010, 222 (03): : 223 - 224
  • [3] Novel therapeutic strategies for MLL-rearranged leukemias
    Wong, Nok-Hei Mickey
    So, Chi Wai Eric
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2020, 1863 (09):
  • [4] The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
    M J Boyer
    T Cheng
    Gene Therapy, 2008, 15 : 117 - 125
  • [5] The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
    Boyer, M. J.
    Cheng, T.
    GENE THERAPY, 2008, 15 (02) : 117 - 125
  • [6] Defining novel therapeutic strategies in MLL-rearranged leukemias
    Faber, J.
    Krivtsov, A.
    Stubbs, M.
    Armstrong, S.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 381 - 382
  • [7] Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
    Banday, Shahid
    Farooq, Zeenat
    Ganai, Shabir Ahmad
    Altaf, Mohammad
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [8] Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
    Shahid Banday
    Zeenat Farooq
    Shabir Ahmad Ganai
    Mohammad Altaf
    Clinical Epigenetics, 2020, 12
  • [9] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Sager, Rebecca A.
    Backe, Sarah J.
    Ahanin, Elham
    Smith, Garrett
    Nsouli, Imad
    Woodford, Mark R.
    Bratslaysky, Gennady
    Bourboulia, Dimitra
    Mollapour, Mehdi
    NATURE REVIEWS UROLOGY, 2022, 19 (05) : 305 - 320
  • [10] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Rebecca A. Sager
    Sarah J. Backe
    Elham Ahanin
    Garrett Smith
    Imad Nsouli
    Mark R. Woodford
    Gennady Bratslavsky
    Dimitra Bourboulia
    Mehdi Mollapour
    Nature Reviews Urology, 2022, 19 : 305 - 320
12345